Department of Gynecology and Obstetrics, Herlev-Gentofte Hospital
Herlev, 2730, Denmark
NCT Number: NCT02676700
This study examines the effect of adding so called Kaatsu training to pelvic floor muscle training. Half the participants will perform Kaatsu training on their thigh muscles followed by pelvic floor muscle training. The other half will receive pelvic floor muscle training alone.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Herlev, 2730, Denmark
Stress urinary incontinence (SU) is a common problem among adult women . Pelvic floor muscle training (PFMT) is recommended as first line treatment but PFMT is not always efficient and some women cannot comply with the intensive PFMT needed to obtain effect because of weakened or damaged muscles caused by vaginal delivery and age related changes.
Hypothetically alternative methods could be used to enhance the effect of a strength-training program. A low intensity training program with a simultaneous partial occlusion of the blood supply for the training muscle, so called "Kaatsu" training has been found to increase muscle strength faster than ordinary strength training but with much less effort. It seems difficult to make occlusion of the pelvic floor muscles during PFMT but a study found that low intensity training of the quadriceps femoris with partial occlusion of the blood supply did not only increase muscle strength of the quadriceps femoris muscle but also of the biceps humeri muscle if that muscle was trained with low-load training and no occlusion in the same training session. The specific reason for this this "cross-transfer effect" could not be fully explained but it was believed to be caused by a systemic effect caused by growth hormones. The aim of this study is therefore to examine if Kaatsu training offered in relation to a low-load PFMT program can increase the effect of PFMT in women with SUI
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention includes three outpatient visits (weeks 0, 6 and 12) and between visits the participants perform PFMT and Kaatsu training as home training
The intervention includes three outpatient visits (weeks 0, 6 and 12) and between visits the participants perform PFMT as home training
Time frame: 12 weeks
Subjective measure of severity of urinary loss and impact on quality of life
Time frame: 6 weeks
Subjective measure of severity of urinary loss and impact on quality of life
Time frame: 12 weeks
UPR is a novel method measuring the pressure and the cross-sectional area of the female urethra. The difference in urethral opening pressure during pelvic floor muscle contraction before and after intervention is measured in cm H2O
Time frame: 6 and 12 weeks
Global scale
Time frame: 6 and 12 weeks
Diary to report number of incontinence episodes
Time frame: 6 and 12 weeks
Scale used to report bother with performing the interventions
Herlev Hospital
Other
The Effect of Pelvic Floor Muscle Training With or Without Kaatsu Training for Women With Stress Urinary Incontinence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04817839
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New Haven, Connecticut, United States
View Trial DetailsNCT06508944
Bladder, Overactive, Female Genitourinary Disease
Ratchathewi, Bangkok, Thailand
View Trial DetailsNCT03672461
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Palo Alto, California, United States
View Trial DetailsNCT05961241
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Haifa, Israel
View Trial Details